Major liver resection for hepatocellular carcinoma in the morbidly obese: A proposed strategy to improve outcome
2008

Liver Surgery Strategy for Obese Patients

Sample size: 1 publication Evidence: low

Author Information

Author(s): Barakat Omar, Skolkin Mark D, Toombs Barry D, Fischer John H II, Ozaki Claire F, Wood R Patrick

Primary Institution: Texas Heart Institute at St. Luke's Episcopal Hospital

Hypothesis

What is the impact of morbid obesity on outcomes after major liver resection for hepatocellular carcinoma?

Conclusion

The approach used in this case could make major liver resection nearly as safe in obese patients as it is in normal-weight patients.

Supporting Evidence

  • The patient had significant comorbidities including hypertension and type II diabetes.
  • Weight loss improved the patient's pulmonary function and reduced medication dosages.
  • The surgical technique involved extensive locoregional therapy and careful planning.

Takeaway

This study shows that with the right treatment plan, even very obese patients can safely undergo major liver surgery.

Methodology

The patient underwent locoregional therapy followed by extended right hepatectomy after a weight-reduction program.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

A 41-year-old morbidly obese woman with a BMI of 56 kg/m2.

Digital Object Identifier (DOI)

10.1186/1477-7819-6-100

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication